DUX4 and Facioscapulohumeral dystrophy: DUX4 target gene expression is very low in blood from ~700 individuals until ~ 20 years of age (within typical FSHD onset range) but then increases and persists through life (unpublished observations), suggesting an age‐dependent mechanism, such as telomere shortening (Stadler et al, 2013).